Literature DB >> 34048122

Structural basis for the stereospecific inhibition of the dual proline/hydroxyproline catabolic enzyme ALDH4A1 by trans-4-hydroxy-L-proline.

Alexandra N Bogner1, Kyle M Stiers1, Cole M McKay1, Donald F Becker2, John J Tanner1,3.   

Abstract

Aldehyde dehydrogenase 4A1 (ALDH4A1) catalyzes the final steps of both proline and hydroxyproline catabolism. It is a dual substrate enzyme that catalyzes the NAD+ -dependent oxidations of L-glutamate-γ-semialdehyde to L-glutamate (proline metabolism), and 4-hydroxy-L-glutamate-γ-semialdehyde to 4-erythro-hydroxy-L-glutamate (hydroxyproline metabolism). Here we investigated the inhibition of mouse ALDH4A1 by the six stereoisomers of proline and 4-hydroxyproline using steady-state kinetics and X-ray crystallography. Trans-4-hydroxy-L-proline is the strongest of the inhibitors studied, characterized by a competitive inhibition constant of 0.7 mM, followed by L-proline (1.9 mM). The other compounds are very weak inhibitors (approximately 10 mM or greater). Insight into the selectivity for L-stereoisomers was obtained by solving crystal structures of ALDH4A1 complexed with trans-4-hydroxy-L-proline and trans-4-hydroxy-D-proline. The structures suggest that the 10-fold greater preference for the L-stereoisomer is due to a serine residue that hydrogen bonds to the amine group of trans-4-hydroxy-L-proline. In contrast, the amine group of the D-stereoisomer lacks a direct interaction with the enzyme due to a different orientation of the pyrrolidine ring. These results suggest that hydroxyproline catabolism is subject to substrate inhibition by trans-4-hydroxy-L-proline, analogous to the known inhibition of proline catabolism by L-proline. Also, drugs targeting the first enzyme of hydroxyproline catabolism, by elevating the level of trans-4-hydroxy-L-proline, may inadvertently impair proline catabolism by the inhibition of ALDH4A1.
© 2021 The Protein Society.

Entities:  

Keywords:  ALDH4A1; L-glutamate-γ-semialdehyde dehydrogenase; X-ray crystallography; aldehyde dehydrogenase; enzyme inhibition; hydroxyproline catabolism; proline metabolism

Mesh:

Substances:

Year:  2021        PMID: 34048122      PMCID: PMC8284585          DOI: 10.1002/pro.4131

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.993


  40 in total

Review 1.  Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases.

Authors:  Marino Convertino; Jhuma Das; Nikolay V Dokholyan
Journal:  ACS Chem Biol       Date:  2016-04-28       Impact factor: 5.100

2.  Human glutamic-gamma-semialdehyde dehydrogenase. Kinetic mechanism.

Authors:  C Forte-McRobbie; R Pietruszko
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

3.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

4.  Structural basis of substrate selectivity of Δ(1)-pyrroline-5-carboxylate dehydrogenase (ALDH4A1): semialdehyde chain length.

Authors:  Travis A Pemberton; John J Tanner
Journal:  Arch Biochem Biophys       Date:  2013-08-06       Impact factor: 4.013

5.  Proline: Mother Nature's cryoprotectant applied to protein crystallography.

Authors:  Travis A Pemberton; Brady R Still; Emily M Christensen; Harkewal Singh; Dhiraj Srivastava; John J Tanner
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-07-17

6.  The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.

Authors:  Brianna Buchalski; Kyle D Wood; Anil Challa; Sonia Fargue; Ross P Holmes; W Todd Lowther; John Knight
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-12-07       Impact factor: 5.187

Review 7.  Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids.

Authors:  Erica Pranzini; Elisa Pardella; Paolo Paoli; Sarah-Maria Fendt; Maria Letizia Taddei
Journal:  Trends Cancer       Date:  2021-03-15

8.  Structural Basis for the Substrate Inhibition of Proline Utilization A by Proline.

Authors:  David A Korasick; Travis A Pemberton; Benjamin W Arentson; Donald F Becker; John J Tanner
Journal:  Molecules       Date:  2017-12-23       Impact factor: 4.411

9.  Structural basis for the stereospecific inhibition of the dual proline/hydroxyproline catabolic enzyme ALDH4A1 by trans-4-hydroxy-L-proline.

Authors:  Alexandra N Bogner; Kyle M Stiers; Cole M McKay; Donald F Becker; John J Tanner
Journal:  Protein Sci       Date:  2021-06-04       Impact factor: 6.993

Review 10.  Genetics of kidney stone disease.

Authors:  Sarah A Howles; Rajesh V Thakker
Journal:  Nat Rev Urol       Date:  2020-06-12       Impact factor: 14.432

View more
  3 in total

Review 1.  Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention.

Authors:  Jie Gao; Yue Hao; Xiangshu Piao; Xianhong Gu
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

2.  Amino acid metabolism genes associated with immunotherapy responses and clinical prognosis of colorectal cancer.

Authors:  Xinyi Peng; Ting Zheng; Yong Guo; Ying Zhu
Journal:  Front Mol Biosci       Date:  2022-08-05

3.  Structural basis for the stereospecific inhibition of the dual proline/hydroxyproline catabolic enzyme ALDH4A1 by trans-4-hydroxy-L-proline.

Authors:  Alexandra N Bogner; Kyle M Stiers; Cole M McKay; Donald F Becker; John J Tanner
Journal:  Protein Sci       Date:  2021-06-04       Impact factor: 6.993

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.